Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
CEO at Inventprise LLC
Dr. Subhash V. Kapre established Inventprise in 2012 to develop solutions to make better vaccines. He was a board member of Serum Institute of India before he started Inventprise. He continues his relationship with the institute in an honorary position as Director Emeritus. Dr. Kapre has over 44 years of experience in research and development, establishing large-scale vaccine manufacture and has been involved with WHO accreditations and uninterrupted supply of scaled, deployed vaccines. He has wide experience in handling bacteria-derived vaccines and virus-derived vaccines. Additionally, he has developed conjugate vaccines and bio-therapeutics such as therapeutic monoclonal antibodies and biopharmaceuticals.
Meningococcal A conjugate vaccine(MenAfriVacc) developed under his leadership is a success story in helping the Sub-Saharan Population. Since 2010, there have been no new cases of Meningitis A reported among vaccinated populations.
At Inventprise under a project grant from the Bill and Melinda Gates foundation he has made a liquid heat stable Rota virus vaccine that can withstand temperatures of 50C for 5 months without loss of virus titer.
Currently he is working on various new ideas in the development of vaccines.